Evidence map›Paper›PMID 24786134›Full record

ReviewTrends in immunology2014

GATA3: a master of many trades in immune regulation.

Yisong Y Wan

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 239 citations in OpenAlex.

  1. Trial
  2. Article
  3. How experimental models have unlocked hidden mechanisms of hypersensitivity pneumonitis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  4. HuR Regulates GATA3-Driven Type 2 Inflammation in CD4bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Nanoengineered GATA3International journal of nanomedicine · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. BHLHE40 Cooperates with GATA2/3 to Control Human Syncytiotrophoblast Lineage Differentiation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Yisong Y WanLineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: wany@email.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

The roles of Gata3 in controlling Treg functionR01AI097392 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WAN, YISONG · 2012 to 2016
$1.8M
Roles for TAK1 in T Cell Development, Function and TumorigenesisR00AI072956 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WAN, YISONG · 2009 to 2010
$498k
NIAID NIH HHS R00 AI072956NIAID NIH HHS R01 AI097392NIAID NIH HHS R01AI097392
6 · The paper itself

Abstract

GATA3 has conventionally been regarded as a transcription factor that drives the differentiation of T helper (Th) 2 cells. Increasing evidence points to a function for GATA3 beyond controlling Th2 differentiation. GATA3 regulates T cell development, proliferation, and maintenance. Furthermore, recent studies have demonstrated important roles for GATA3 in innate lymphoid cells. Thus, GATA3 emerges as a factor with diverse functions in immune regulation, which are in some cases cell-type specific and in others shared by multiple cell types. Here, I discuss recent discoveries and the current understanding of the functions of GATA3 in immune regulation.

Indexed as

Adaptive ImmunityAnimalsGATA3 Transcription FactorGene Expression RegulationHumansImmunityImmunity, InnateLymphocyte ActivationLymphocyte SubsetsSignal TransductionGATA3 Transcription FactorGATA3innate lymphoid cellnatural killer cellnatural killer T cellT cellTreg cell

Identifiers

PMID24786134
PMCPMC4045638
OpenAlexW2062874382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.